Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially ...

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumours may potentially be more susceptible to ...

Scientists of the University Medical Center Göttingen (UMG) have identified new interactions between pancreatic cancer cells ...

This discovery is exciting because it opens up a new way to fight pancreatic cancer. If doctors can develop treatments that ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

Personalized ctDNA monitoring to assess the recurrence of early stage pancreatic cancer after surgery. Validation of PDACai v2.0 in predicting relative benefit from ...

High-dose intravenous vitamin C combined with standard chemotherapy significantly extends survival in patients with metastatic pancreatic cancer. Learn more.

The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the University of ...

Strong median overall survival (OS) figures for various pancreatic cancer subgroups treated with ... a checkpoint inhibitor (pembrolizumab) for recurrent unresectable or metastatic head and ...

Medical announced positive interim data from multiple clinical trials, including safety and feasibility studies treating ...